Huiren Shenbao tablets are not recommended for long-term use, and the specific medication cycle should be adjusted according to medical advice. This medicine is mainly used for symptoms such as waist and knee tenderness and frequent nocturnal urination caused by kidney yang deficiency. It belongs to the regulation category of traditional Chinese patent medicines and simple preparations, and long-term use may affect the body's self-regulation function.
Huiren Shenbao tablets contain more than 20 traditional Chinese medicinal herbs such as Rehmannia glutinosa, Psoraleae, and Goji berries. Short term use can improve symptoms of kidney yang deficiency. However, traditional Chinese medicine emphasizes stopping the disease immediately and gradually reducing the dosage after the symptoms are relieved. Continuous use may mask potential disease progression, such as chronic kidney disease or endocrine disorders. Long term intake of certain components may increase the metabolic burden on the liver and kidneys, especially for those with abnormal liver function who need to be cautious. A small number of patients can extend their medication cycle under the guidance of a doctor, such as elderly patients with severe kidney yang deficiency and osteoporosis, but regular monitoring of liver and kidney function is necessary. In common clinical combination therapy regimens, this drug is usually used as a staged adjuvant therapy, and is more effective when combined with lifestyle interventions. If there is discomfort such as decreased appetite and dry mouth and tongue during the use of SEP, the medication should be stopped immediately. Daily recommendations include coordinated regulation through moxibustion at the Shenshu acupoint and moderate aerobic exercise to avoid excessive dependence on medication. Traditional Chinese patent medicines and simple preparations conditioning needs to follow the principle of individualization. It is recommended to return every three months to assess the necessity of medication and adjust the plan in time.
Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!